Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient

Virology

Volumn 435, Issue 2, 2013, Pages 320-328

  Hu, Weibin ^a   Chen, Aizhong ^b   Miao, Yi ^c   Xia, Shengli ^d   Ling, Zhiyang ^a   Xu, Ke ^a   Wang, Tongyan ^a   Xu, Ying ^b   Cui, Jun ^b   Wu, Hongqiang ^b   Hu, Guiyu ^b   Tian, Lin ^b   Wang, Lingling ^b   Shu, Yuelong ^d   Ma, Xiaowei ^e   Xu, Bianli ^d   Zhang, Jin ^d   Lin, Xiaojun ^e   Bian, Chao ^b   Sun, Bing ^a,b  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c SHANGHAI XUHUI CENTRAL HOSPITAL   (China)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e Hualan Biological Bacterin Company   (China)

Author keywords

Epitope; Fully human monoclonal antibody; Fusion peptide; H1N1; HA2; Influenza; MAb; Neutralization; Single cell RT PCR; TCID50

Indexed keywords

ASPARTIC ACID; EPITOPE; GLUTAMIC ACID; GLYCINE; HISTIDINE; HYBRID PROTEIN; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; ISOLEUCINE; METHIONINE; NEUTRALIZING ANTIBODY; PHENYLALANINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE;

2009 H1N1 INFLUENZA; ADULT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; INFLUENZA VIRUS A H1N1; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; RECIPIENT;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-LYMPHOCYTES; EPITOPE MAPPING; EPITOPES; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; PANDEMICS; PEPTIDES;

INFLUENZA A VIRUS;

EID: 84871692172     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.09.034     Document Type: Article

References (27)

1. Burioni R., Canducci F., Mancini N., Clementi N., Sassi M., De Marco D., Diotti R.A., Saita D., Sampaolo M., Sautto G., Pianezze M., Clementi M. Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV). Virology 2010, 399:144-152.
2. Corti D., Suguitan A.L., Pinna D., Silacci C., Fernandez-Rodriguez B.M., Vanzetta F., Santos C., Luke C.J., Torres-Velez F.J., Temperton N.J., Weiss R.A., Sallusto F., Subbarao K., Lanzavecchia A. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J. Clin. Invest. 2010, 120:1663-1673.
3. Clementi N., De Marco D., Mancini N., Solforosi L., Moreno G.J., Gubareva L.V., Mishin V., Di Pietro A., Vicenzi E., Siccardi A.G., Clementi M., Burioni R. A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes. PLoS One 2011, 6:e28001.
4. Corti D., Voss J., Gamblin S.J., Codoni G., Macagno A., Jarrossay D., Vachieri S.G., Pinna D., Minola A., Vanzetta F., Silacci C., Fernandez-Rodriguez B.M., Agatic G., Bianchi S., Giacchetto-Sasselli I., Calder L., Sallusto F., Collins P., Haire L.F., Temperton N., Langedijk J.P., Skehel J.J., Lanzavecchia A. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011, 333:850-856.
5. De Marco D., Clementi N., Mancini N., Solforosi L., Moreno G.J., Sun X., Tumpey T.M., Gubareva L.V., Mishin V., Clementi M., Burioni R. A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses. PLoS One 2012, 7:e34415.
6. Dong J., Matsuoka Y., Maines T.R., Swayne D.E., O'Neill E., Davis C.T., Van-Hoven N., Balish A., Yu H.J., Katz J.M., Klimov A., Cox N., Li D.X., Wang Y., Guo Y.J., Yang W.Z., Donis R.O., Shu Y.L. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production. Influenza Other Respir. Viruses 2009, 3:287-295.
7. Ekiert D.C., Bhabha G., Elsliger M.A., Friesen R.H., Jongeneelen M., Throsby M., Goudsmit J., Wilson I.A. Antibody recognition of a highly conserved influenza virus epitope. Science 2009, 324:246-251.
8. Ekiert D.C., Friesen R.H., Bhabha G., Kwaks T., Jongeneelen M., Yu W., Ophorst C., Cox F., Korse H.J., Brandenburg B., Vogels R., Brakenhoff J.P., Kompier R., Koldijk M.H., Cornelissen L.A., Poon L.L., Peiris M., Koudstaal W., Wilson I.A., Goudsmit J. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011, 333:843-850.
9. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., de Graaf M., Burke D.F., Fouchier R.A., Pappas C., Alpuche-Aranda C.M., López-Gatell H., Olivera H., López I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson P.D., Boxrud D., Sambol A.R., Abid S.H., St George K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., Demmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., Cox N.J. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
10. Godley L., Pfeifer J., Steinhauer D., Ely B., Shaw G., Kaufmann R., Suchanek E., Pabo C., Skehel J.J., Wiley D.C., Wharton S. Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity. Cell 1992, 68:635-645.
11. Goto H., Kawaoka Y. A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc. Natl. Acad. Sci. U S A 1998, 95:10224-10228.
12. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., Liu F., Dong L., DeVos J.R., Gargiullo P.M., Brammer T.L., Cox N.J., Tumpey T.M., Katz J.M. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 2009, 361:1945-1952.
13. Hung I.F., To K.K., Lee C.K., Lee K.L., Chan K., Yan W.W., Liu R., Watt C.L., Chan W.M., Lai K.Y., Koo C.K., Buckley T., Chow F.L., Wong K.K., Chan H.S., Ching C.K., Tang B.S., Lau C.C., Li I.W., Liu S.H., Chan K.H., Lin C.K., Yuen K.Y. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin. Infect. Dis. 2011, 52:447-456.
14. Liang X.F., Wang H.Q., Wang J.Z., Fang H.H., Wu J., Zhu F.C., Li R.C., Xia S.L., Zhao Y.L., Li F.J., Yan S.H., Yin W.D., An K., Feng D.J., Cui X.L., Qi F.C., Ju C.J., Zhang Y.H., Guo Z.J., Chen P.Y., Chen Z., Yan K.M., Wang Y. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010, 375:56-66.
15. Okuno Y., Isegawa Y., Sasao F., Ueda S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 1993, 67:2552-2558.
16. Palese P. Influenza: old and new threats. Nat. Med. 2004, 10:S82-87.
17. Prabhu N., Prabakaran M., Ho H.T., Velumani S., Qiang J., Goutama M., Kwang J. Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection. J. Virol. 2009, 83:2553-2562.
18. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., Fukuda K., Cox N.J., Katz J.M. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 1999, 37:937-943.
19. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69:531-569.
20. Smith K., Garman L., Wrammert J., Zheng N.Y., Capra J.D., Ahmed R., Wilson P.C. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 2009, 4:372-384.
21. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.M., Santelli E., Stec B., Cadwell G., Ali M., Wan H., Murakami A., Yammanuru A., Han T., Cox N.J., Bankston L.A., Donis R.O., Liddington R.C., Marasco W.A. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 2009, 16:265-273.
22. Sakabe S., Iwatsuki-Horimoto K., Horimoto T., Nidom C.A., Le M.Q., Takano R., Kubota-Koketsu R., Okuno Y., Ozawa M., Kawaoka Y. A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection. Antiviral Res. 2010, 88:249-255.
23. Walls H.H., Harmon M.W., Slagle J.J., Stocksdale C., Kendal A.P. Characterization and evaluation of monoclonal antibodies developed for typing influenza A and influenza B viruses. J. Clin. Microbiol. 1986, 23:240-245.
24. Wang K., Holtz K.M., Anderson K., Chubet R., Mahmoud W., Cox M.M. Expression and purification of an influenza hemagglutinin-one step closer to a recombinant protein-based influenza vaccine. Vaccine 2006, 24:2176-2185.
25. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., Zheng N.Y., Mays I., Garman L., Helms C., James J., Air G.M., Capra J.D., Ahmed R., Wilson P.C. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667-671.
26. Wrammert J., Koutsonanos D., Li G.M., Edupuganti S., Sui J., Morrissey M., McCausland M., Skountzou I., Hornig M., Lipkin W.I., Mehta A., Razavi B., Del Rio C., Zheng N.Y., Lee J.H., Huang M., Ali Z., Kaur K., Andrews S., Amara R.R., Wang Y., Das S.R., O'Donnell C.D., Yewdell J.W., Subbarao K., Marasco W.A., Mulligan M.J., Compans R., Ahmed R., Wilson P.C. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 2011, 208:181-193.
27. Zhu F.C., Wang H., Fang H.H., Yang J.G., Lin X.J., Liang X.F., Zhang X.F., Pan H.X., Meng F.Y., Hu Y.M., Liu W.D., Li C.G., Li W., Zhang X., Hu J.M., Peng W.B., Yang B.P., Xi P., Wang H.Q., Zheng J.S. A novel influenza A (H1N1) vaccine in various age groups. N. Engl. J. Med. 2009, 361:2414-2423.